| Dermatology and Skin Diseases | Lifetime | 161 | DK 10 | 99.06 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 100 | DK 4 | 99.04 |
| Acne and Rosacea Treatments and Effects | Lifetime | 55 | DK 4 | 98.59 |
| Allergic Rhinitis and Sensitization | Lifetime | 498 | DK 18 | 98.06 |
| Pharmacological Effects of Natural Compounds | Lifetime | 544 | DK 2 | 96.54 |
| Spondyloarthritis Studies and Treatments | Lifetime | 249 | DK 6 | 97.46 |
| Pharmaceutical studies and practices | Lifetime | 559 | DK 10 | 96.27 |
| melanin and skin pigmentation | Lifetime | 380 | DK 2 | 96.20 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 78 | DK 7 | 95.23 |
| Food Allergy and Anaphylaxis Research | Lifetime | 730 | DK 24 | 95.56 |
| Autoimmune Bullous Skin Diseases | Lifetime | 833 | DK 11 | 94.81 |
| Urticaria and Related Conditions | Lifetime | 733 | DK 11 | 94.58 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 782 | DK 35 | 94.25 |
| Biosimilars and Bioanalytical Methods | Lifetime | 533 | DK 7 | 92.48 |
| Contact Dermatitis and Allergies | Lifetime | 978 | DK 40 | 93.38 |
| Hair Growth and Disorders | Lifetime | 624 | DK 4 | 89.65 |
| Historical Medical Research and Treatments | Lifetime | 857 | DK 19 | 47.40 |
| Dermatology and Skin Diseases | 2021-2025 | 42 | DK 2 | 99.31 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 34 | DK 1 | 99.18 |
| Pharmaceutical studies and practices | 2021-2025 | 31 | DK 1 | 97.24 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 257 | DK 5 | 97.36 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 120 | DK 3 | 97.92 |
| Asthma and respiratory diseases | 2021-2025 | 359 | DK 10 | 96.72 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 46 | DK 1 | 94.62 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 164 | DK 1 | 94.35 |
| Contact Dermatitis and Allergies | 2021-2025 | 96 | DK 7 | 94.12 |
| Food Allergy and Anaphylaxis Research | 2021-2025 | 194 | DK 6 | 94.95 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 192 | DK 9 | 94.33 |
| Hair Growth and Disorders | 2021-2025 | 115 | DK 1 | 89.61 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 560 | DK 19 | 92.09 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 110 | DK 7 | 87.66 |
| Colorectal and Anal Carcinomas | 2021-2025 | 768 | DK 17 | 84.86 |
| Microscopic Colitis | 2021-2025 | 850 | DK 29 | 87.37 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 464 | DK 7 | 82.95 |
| Dermatologic Treatments and Research | 2021-2025 | 504 | DK 4 | 83.43 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | 2021-2025 | 844 | DK 33 | 78.94 |
| Urticaria and Related Conditions | 2021-2025 | 763 | DK 8 | 78.14 |
| Pregnancy and Medication Impact | 2021-2025 | 823 | DK 25 | 74.40 |
| Chemotherapy-related skin toxicity | 2021-2025 | 832 | DK 21 | 31.78 |
